Harrell, Melissa B.
Clendennen, Stephanie L.
Sumbe, Aslesha
Case, Kathleen R.
Mantey, Dale S.
Swan, Sunaina
Funding for this research was provided by:
National Cancer Institute (1R01CA239097, T32/CA057712)
Article History
Accepted: 26 April 2022
First Online: 7 May 2022
Declarations
:
: Dr. Harrell reports grants from NIH/NCI, during the conduct of the study; personal fees from XX is a consultant in litigation involving the vaping industry, outside the submitted work. Dr. Clendennen reports grants from NIH/NCI, during the conduct of the study; personal fees from XX is a consultant in litigation involving the vaping industry, outside the submitted work. Sumbe A. reports grants from NIH/NCI, during the conduct of the study. Dr. Case has nothing to disclose. Dr. Mantey reports grants from NIH/NCI, during the conduct of the study; personal fees from XX is a consultant in litigation involving the vaping industry, outside the submitted work. Swan. S reports grants from NIH/NCI, during the conduct of the study.
: This article does not contain any studies with human or animal subjects performed by any of the authors.